Strengthening Families & Communities LLC Has $1.56 Million Stake in Cardinal Health, Inc. $CAH

Key Points

• Strengthening Families & Communities LLC significantly increased its stake in Cardinal Health by 6,124.8% during Q2, now holding 9,275 shares valued at approximately $1.56 million.
• Institutional investors own 87.17% of Cardinal Health's stock, with notable increases from several major investors, including Wellington Management and JPMorgan Chase.
• Cardinal Health reported $2.08 EPS for the last quarter, slightly exceeding analysts' expectations, alongside a quarterly dividend announcement of $0.5107 per share.

Strengthening Families & Communities LLC grew its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6,124.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,275 shares of the company's stock after purchasing an additional 9,126 shares during the quarter. Strengthening Families & Communities LLC's holdings in Cardinal Health were worth $1,558,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CAH. Wellington Management Group LLP grew its position in shares of Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after buying an additional 1,193,983 shares during the period. Zurich Insurance Group Ltd FI boosted its stake in shares of Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock valued at $130,434,000 after buying an additional 927,950 shares during the period. Nuveen LLC bought a new stake in shares of Cardinal Health in the first quarter valued at approximately $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new stake in shares of Cardinal Health in the first quarter valued at approximately $104,951,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Cardinal Health in a report on Wednesday. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Wall Street Zen downgraded Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Finally, Citigroup reiterated a "neutral" rating and issued a $170.00 price target (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $166.00.

Cardinal Health Stock Down 0.2%

Shares of NYSE:CAH opened at $156.86 on Friday. The business has a fifty day simple moving average of $152.09 and a 200 day simple moving average of $151.09. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44. The firm has a market cap of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the business posted $1.84 EPS. The business's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.

Insider Buying and Selling

In other news, insider Ola M. Snow sold 28,151 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares of the company's stock, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.12% of the stock is owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.